Livent (LTHM) & Its Peers Critical Analysis

Livent (NYSE: LTHM) is one of 27 publicly-traded companies in the “Chemicals & allied products” industry, but how does it contrast to its rivals? We will compare Livent to similar businesses based on the strength of its analyst recommendations, dividends, risk, profitability, valuation, institutional ownership and earnings.


This table compares Livent and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Livent 19.88% 19.98% 14.87%
Livent Competitors -44.39% 20.04% 5.39%

Earnings & Valuation

This table compares Livent and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Livent $442.50 million $126.10 million 7.51
Livent Competitors $7.43 billion $509.65 million 12.01

Livent’s rivals have higher revenue and earnings than Livent. Livent is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

98.0% of Livent shares are held by institutional investors. Comparatively, 72.3% of shares of all “Chemicals & allied products” companies are held by institutional investors. 0.7% of Livent shares are held by company insiders. Comparatively, 8.9% of shares of all “Chemicals & allied products” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings for Livent and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Livent 2 6 6 0 2.29
Livent Competitors 223 757 991 45 2.43

Livent presently has a consensus target price of $15.12, indicating a potential upside of 121.40%. As a group, “Chemicals & allied products” companies have a potential upside of 22.32%. Given Livent’s higher probable upside, equities analysts plainly believe Livent is more favorable than its rivals.


Livent rivals beat Livent on 8 of the 12 factors compared.

About Livent

Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries. Livent Corporation was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with's FREE daily email newsletter.